It’s been awhile since we stopped publishing a weekly linkfest about Covid-19. However a pandemic-related item this week is worth highlighting. In a study, researchers estimated that nearly 20 million lives were saved in 2021 due to the introduction of Covid-19 vaccines. Even if this number if off by a bit, it still constitutes a nearly unfathomable achievement.

The benefits of the Covid-19 vaccines were centered in the wealthiest countries where they were rolled out initially. The reduction in harm came both from the direct, and indirect, effects of vaccination. The paper points out that the inability to get vaccines to low income countries was a failure.

Source: The Lancet

None of this could have been possible without the efforts of a number of companies. Below is a chart of the market caps of some of the most prominent. Both Moderna and BioNTech saw big increases in their value over this period, but they are both well off of their mid-2021 highs.

Source: YCharts

Nobody knows when the next pandemic is coming or whether the mRNA platforms will be useful in other disease states. But for as bad as the pandemic was in the U.S. and elsewhere it could have been much, much worse.

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Please see disclosures here.

Please see the Terms & Conditions page for a full disclaimer.